Item Number: AQUPHARM3
Aqupharm No.3 Solution for Infusion for Cats and Dogs.
For the treatment of dehydration to correct water and electrolyte depletion where the patient's carbohydrate store is considered to be depleted. It is also indicated in the management of Addisonian crisis and urethral obstruction.
Amount(s) to be administered and administration route:
Remove outer bag and protective giving set inlet tab. Push cannula fully into giving set. Prime giving set. Perform venepuncture and immediately attach giving set.
Adjust infusion rate as required. Delivery is from a closed circuit, it does not need an air inlet.
Giving sets should be changed every 24 hours.
The quantity of fluid and electrolyte for administration will consider existing deficits, maintenance needs and continuing losses.
The existing deficit is that which has been lost prior to examination. This must be estimated by evaluating the patient's history, making a physical examination and using laboratory aids. Maintenance therapy is to replace normal losses occurring via urine, faeces, respiratory tract and skin. As a general rule, maintenance therapy requires 50 ml/kg bodyweight/day. Continuing losses during a disease period should be estimated whenever possible, i.e., quantity of vomit, diarrhoea or blood loss.
The clinical response of the animal rather than formulae or equations should be used to guide fluid therapy. The intravenous route of administration is preferred. Indwelling intravenous catheters offer significant advantage in intravenous fluid
therapy. Subcutaneous administration may be used for isotonic and non-irritating solutions.
The rate of administration should be considered with each individual patient. The aim should be to correct about half of the calculated deficit in the first 1-2 hours. As a general rule the following formula is the maximum satisfactory rate (less where cardiovascular or pulmonary disease exists).
Maximum rate = Body wt (kg) × 90 = ml fluid per hour
This rate should be slowed after the first hour and considerably slowed if no urine flow is established. Signs of over rapid administration include restlessness, moist lung sounds, tachycardia, tachypnoea, nasal discharge, coughing, vomiting and diarrhoea.
Nature and composition of immediate packaging:
Packaging Format 1
A colourless, transparent, flexible polyvinyl chloride (PVC) bag with a blue PVC twist off giving set port and a re-sealable additives port, containing 500 ml
1000 ml clear, colourless solution.
PVC bags are overwrapped with HDPE.
Packaging Format 2
A colourless, transparent flexible polyvinyl chloride (PVC) bag with re-sealable polyisoprene/polycarbonate giving set and additive ports, containing 500ml or 1000ml clear colourless solution.
PVC bags are overwrapped with polypropylene.
Cardboard box containing
20 bags of 500 ml solution for infusion
10 bags of 1000 ml solution for infusion
Not all pack sizes may be marketed.
AQUPHARM3 500ML: Data Sheet